Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Perivascular Epithelioid Cell Neoplasms”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Not applicableStudy completedNCT02859194
What this trial is testing

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

Who this might be right for
Interstitial Pulmonary Fibrosis ARDSCOPD (Chronic Obstructive Pulmonary Disease)Bronchiectasis+3 more
Yonsei University 10
Testing effectiveness (Phase 2)UnknownNCT05190627
What this trial is testing

Effect of Loratadine in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Institut d'Investigació Biomèdica de Bellvitge 62
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Not applicableActive Not RecruitingNCT06453642
What this trial is testing

Evaluation of a Simple-Prep Controlled Embolic

Who this might be right for
EmbolizationVascular TumorRenal Angiomyolipoma+3 more
Fluidx Medical Technology, Inc. 114
Testing effectiveness (Phase 2)UnknownNCT00490789
What this trial is testing

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Cardiff University 14
Post-approval studies (Phase 4)Active Not RecruitingNCT05252585
What this trial is testing

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Who this might be right for
Renal Angiomyolipoma
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)Study completedNCT02494570
What this trial is testing

Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

Who this might be right for
Malignant PEComa
Aadi Bioscience, Inc. 34
Not applicableStudy completedNCT00005486
What this trial is testing

Lymphangioleiomyomatosis (LAM) Registry

Who this might be right for
Lung DiseasesLymphangiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Not applicableApproved For MarketingNCT03817515
What this trial is testing

Expanded Access for ABI-009 in Patients With Advanced PEComa and Patients With a Malignancy With Relevant Genetic Mutations or mTOR Pathway Activation

Who this might be right for
PEComa, MalignantTSC1TSC2+1 more
Aadi Bioscience, Inc.
Not applicableStudy completedNCT04184193
What this trial is testing

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

Who this might be right for
LymphangioleiomyomatosisLAMPulmonary Rehabilitation
Schön Klinik Berchtesgadener Land 58
Not applicableLooking for participantsNCT03193892
What this trial is testing

A National Registry on Chinese Patients With Lymphangioleiomyomatosis

Who this might be right for
Pulmonary Function
Peking Union Medical College Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT00126672
What this trial is testing

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Who this might be right for
Nonmalignant NeoplasmTuberous SclerosisLymphangioleimyomatosis+1 more
Dana-Farber Cancer Institute 36
Not applicableUnknownNCT03916575
What this trial is testing

PEComas: Natural History and Prognostic Factors

Who this might be right for
PEComas
University Hospital, Strasbourg, France 60
Not applicableLooking for participantsNCT02432560
What this trial is testing

Safety and Durability of Sirolimus for Treatment of LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 600
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Testing effectiveness (Phase 2)Looking for participantsNCT01799538
What this trial is testing

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableEnrolling By InvitationNCT05727852
What this trial is testing

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Who this might be right for
Chronic Respiratory DiseasesCystic FibrosisLymphangioleiomyomatosis+4 more
I.M. Sechenov First Moscow State Medical University 400
Large-scale testing (Phase 3)Study completedNCT00414648
What this trial is testing

Efficacy and Safety of Sirolimus in LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 89
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Load More Results